CHICAGO (EGMN) - A stimulated thyroglobulin measurement obtained 3 months after total thyroidectomy for well-differentiated thyroid carcinoma provides an objective means of identifying patients who can safely be spared radioactive iodine therapy for remnant ablation, according to a Canadian study. The rate of radioiodine remnant ablation in patients who were evaluated using this protocol was only about one-fourth what it would have been using current American Thyroid Association (ATA) guidelines,...